Hambley H, Davidson J F, Walker I D, Small M, Prentice C R
J Clin Pathol. 1983 May;36(5):574-6. doi: 10.1136/jcp.36.5.574.
Freeze dried cryoprecipitate was used in the treatment of 14 patients with haemophilia A. The in vivo recovery was 91.2% which is comparable to that reported from other parts of Europe. The product was efficacious and no adverse effects were reported. Freeze dried cryoprecipitate is the high yield product of a low technology process and as such may be of value in reducing any possible shortfall in the factor VIII requirements of the haemophiliac population of the UK.
冻干冷沉淀用于治疗14例甲型血友病患者。体内回收率为91.2%,与欧洲其他地区报道的结果相当。该产品有效,且未报告有不良反应。冻干冷沉淀是一种低技术工艺的高产产品,因此在减少英国血友病患者可能出现的凝血因子VIII需求短缺方面可能具有价值。